These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6646263)

  • 21. [Effect of chemoradiotherapy on the pituitary-thyroid system in children with Hodgkin's disease].
    Konoplia NE; Savichko NV; Zhavrid EA
    Vopr Onkol; 1997; 43(4):395-9. PubMed ID: 9381687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid abnormalities following neck irradiation for Hodgkin's disease.
    Nelson DF; Reddy KV; O'Mara RE; Rubin P
    Cancer; 1978 Dec; 42(6):2553-62. PubMed ID: 728860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid function 10-18 years after mantle field irradiation for Hodgkin's disease.
    Peerboom PF; Hassink EA; Melkert R; DeWit L; Nooijen WJ; Bruning PF
    Eur J Cancer; 1992; 28A(10):1716-8. PubMed ID: 1389492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aorto-duodenal fistula following abdominal irradiation for Hodgkin's disease. A case report.
    Zarembok I; Brace KC
    J Can Assoc Radiol; 1972 Dec; 23(4):267-8. PubMed ID: 4646897
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pneumothorax following radiotherapy of Hodgkin's disease].
    Desablens B; Venet P; Muir JF
    Ann Med Interne (Paris); 1989; 140(1):52-3. PubMed ID: 2660654
    [No Abstract]   [Full Text] [Related]  

  • 26. Thyroid cancer following radiotherapy for Hodgkin's disease: a case report and review of the literature.
    Moroff SV; Fuks JZ
    Med Pediatr Oncol; 1986; 14(4):216-20. PubMed ID: 3747940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Is it possible to avoid hematologic toxicity of radiotherapy in Hodgkin's disease (HD)?].
    Peiffert D
    Bull Cancer; 1991; 78(10):865-8. PubMed ID: 1768933
    [No Abstract]   [Full Text] [Related]  

  • 28. Rare, late complications in a patient with Hodgkin's disease.
    Illés A; Gergely L; Miltényi Z; Keresztes K; Olvasztó S; Redl P; Dankó K
    Haematologia (Budap); 2002; 32(4):509-18. PubMed ID: 12803127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid function after mantle irradiation in Hodgkin's disease.
    Smith RE; Adler RA; Clark P; Brinck-Johnsen T; Tulloh ME; Colton T
    JAMA; 1981 Jan; 245(1):46-9. PubMed ID: 6253696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypothyroid hypertrophic myopathy following mantle irradiation for Hodgkin's disease. A case].
    Weber JC; Dufour P; Maloisel F; Tranchant C; Jung G; Damonte JC; Giron C; Oberling F
    Rev Med Interne; 1991; 12(3):205-8. PubMed ID: 1896713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid function in pediatric patients after neck irradiation for Hodgkin disease.
    Green DM; Brecher ML; Yakar D; Blumenson LE; Lindsay AN; Voorhess ML; MacGillivray M; Freeman AI
    Med Pediatr Oncol; 1980; 8(2):127-36. PubMed ID: 7421731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation-induced coronary artery disease in Hodgkin's disease.
    Miltényi Z; Keresztes K; Garai I; Edes I; Galajda Z; Tóth L; Illés A
    Cardiovasc Radiat Med; 2004; 5(1):38-43. PubMed ID: 15275631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radiation pericarditis following treatment of lymphogranulomatosis].
    Baĭsogolov GD; Shishkin IP; Shapiro IB
    Med Radiol (Mosk); 1983 Sep; 28(9):27-31. PubMed ID: 6688649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of lymphangiography on the development of hypothyroidism in patients irradiated for Hodgkin's disease.
    Fein DA; Hanlon AL; Corn BW; Curran WJ; Coia LR
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):13-8. PubMed ID: 8823254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroxine administration during radiation therapy to the neck does not prevent subsequent thyroid dysfunction.
    Bantle JP; Lee CK; Levitt SH
    Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):1999-2002. PubMed ID: 3932271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term cardiovascular evaluation of patients with Hodgkin's disease treated by thoracic mantle radiation therapy.
    Applefeld MM; Slawson RG; Spicer KM; Singleton RT; Wesley MN; Wiernik PH
    Cancer Treat Rep; 1982 Apr; 66(4):1003-13. PubMed ID: 7074628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lymph node calcification in Hodgkin's disease following irradiation (author's transl)].
    Shibuya H; Horiuchi J; Matsubara S; Okuyama T; Suzuki S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Oct; 38(10):936-9. PubMed ID: 733466
    [No Abstract]   [Full Text] [Related]  

  • 39. Phantom measurements and computed estimates of breast dose with radiotherapy for Hodgkin's lymphoma: dose reduction with the use of the involved field.
    Wirth A; Kron T; Wittwer H; Sullivan K; Sorell G; Cramb J
    J Med Imaging Radiat Oncol; 2008 Aug; 52(4):394-402. PubMed ID: 18811765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.